Menu
Not yet recruiting NCT07117253

Interstitial Lung Diseases in Respiratory ICU

Observational Interstitial Lung Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Interstitial Lung Diseases. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Factors Affecting Outcome of Patients With Interstitial Lung Diseases in Respiratory Intensive Care Unit

Overview

This is Prospective observational study to analyze the clinical features, risk factors, outcome,mortality rates in interstitial lung diseases patients who required admission in Respiratory ICU

Primary outcome measures

  • Number of participants with Complications of disease [Time frame: 1 month after icu admission]
  • Evaluate Length of respiratory ICU stay [Time frame: 1 month after icu admission]
  • Assess mortality of patients with interstitial lung diseases in respiratory icu. [Time frame: 1 month after icu admission]

Eligibility criteria

Inclusion criteria

  • Patients who had diagnosis of interstitial lung diseases required admission in respiratory ICU

Exclusion criteria

  • Patients with respiratory diseases other than ILD

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07117253 · Soh-Med-24-10-8MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗